...
首页> 外文期刊>Human Molecular Genetics >A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population
【24h】

A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population

机译:全基因组关联研究揭示了韩国人群中非小细胞肺癌的易感性变异

获取原文

摘要

Lung cancer is one of the most common cancers and the major cause of cancer death, both in Korea and worldwide, with non-small cell lung cancer (NSCLC) as the predominant histologic type. To identify genetic risk factors, we here conducted a genome-wide association study (GWAS) and a replication study in 1425 patients with NSCLC and 3011 controls from Korea. From the data for 2162 participants analyzed using the Affymetrix Genome-wide Human SNP array 5.0K, 168 single nucleotide polymorphisms (SNPs) were selected for validation. In the second stage, we were able to genotype 168 SNPs in 804 patients and 1470 controls to confirm the results of the GWAS. In the meta-analysis, rs2131877 at the chromosome 3q29 region was the most significant biomarker of lung cancer susceptibility in Koreans (P = 2.43 × 10–8). Four markers that were located within the chromosome 3q29 region were also associated with lung cancer susceptibility (trend P < 1.2 × 10–4), along with markers on 5p15 that were previously reported in populations of European descent. This high-density large-scale GWAS carried out in the Korean population suggests that 3q29 is a novel susceptibility region associated with lung cancer susceptibility in Koreans.
机译:在韩国和世界范围内,肺癌是最常见的癌症之一,也是导致癌症死亡的主要原因,非小细胞肺癌(NSCLC)是主要的组织学类型。为了确定遗传风险因素,我们在这里对来自韩国的1425例NSCLC患者和3011例对照进行了全基因组关联研究(GWAS)和复制研究。从使用Affymetrix全基因组人类SNP阵列5.0K分析的2162名参与者的数据中,选择168个单核苷酸多态性(SNP)进行验证。在第二阶段,我们能够对804名患者和1470名对照进行168个SNP的基因分型,以确认GWAS的结果。在荟萃分析中,染色体3q29区域的rs2131877是韩国人肺癌易感性的最重要生物标志物(P = 2.43×10 -8 )。位于3q29染色体区域内的四个标记也与肺癌易感性相关(趋势P <1.2×10 –4 ),以及先前在欧洲血统人群中报道的5p15标记。在韩国人群中进行的这种高密度大规模GWAS表明,3q29是与韩国人肺癌易感性相关的新型易感性区域。

著录项

  • 来源
    《Human Molecular Genetics 》 |2010年第24期| p.4948-4954| 共7页
  • 作者单位

    Research Institute and Hospital, National Cancer Center, Gyeonggi, South Korea,;

    Research Institute and Hospital, National Cancer Center, Gyeonggi, South Korea,;

    Research Institute and Hospital, National Cancer Center, Gyeonggi, South Korea,;

    National Cancer Control Research Institute, Goyang, Gyeonggi, South Korea,;

    Research Institute and Hospital, National Cancer Center, Gyeonggi, South Korea,;

    Research Institute and Hospital, National Cancer Center, Gyeonggi, South Korea,;

    Research Institute and Hospital, National Cancer Center, Gyeonggi, South Korea,;

    Research Institute and Hospital, National Cancer Center, Gyeonggi, South Korea,;

    DNA Link, Seoul, South Korea,;

    Center for Genomic Medicine, RIKEN, Yokohama, Japan and;

    Center for Genomic Medicine, RIKEN, Yokohama, Japan and;

    Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号